Hospital, Bristol, UK, BS10 5NB. +44 (0)1174148186. John.grogan@bristol.ac.uk. 10 11 ACKNOWLEDGEMENTS 12 The authors thank BRACE for the use of their building, all the patients and 13 participants who took part in this research, and the funders (Wellcome [097081/Z/11/Z] and 14 Bristol Research into Alzheimer's and Care of the Elderly charity [BRI17/15]). 15 16 ABSTRACT 17 Rationale 18
items in memory for short periods of time and manipulate them. There is conflicting evidence 20 on the nature of the deficits caused by the disease, and the potential beneficial and 21 detrimental effects of dopaminergic medication on different WM processes. 22
Objectives 23
We hypothesised that PD impairs both maintenance and manipulation of items in WM 24 and dopaminergic medications improve this in PD patients but impair it in healthy older 25 adults. 26
Methods 27
We tested 68 PD patients ON and OFF their dopaminergic medication, 83 healthy 28 age-matched controls, and 30 healthy older adults after placebo and levodopa administration. 29
We used the digit span, a WM test with three components (forwards, backwards and sequence 30 recall) that differ in the amount of manipulation required. We analysed the maximum spans 31 and the percentage of lists correctly recalled, which probe capacity of WM and the accuracy 32 of the memory processes within this capacity, respectively. 33
Results 34
INTRODUCTION
Working memory (WM) involves the maintenance and manipulation of elements held 48 in memory for short periods of time. Early models suggested WM is composed of 49 phonological and visuospatial storage components, and a central executive that manages 50 attentional demands and the manipulation of stored elements (Baddeley, 2012) . 51
Parkinson's disease (PD) patients have impaired WM, especially for visuospatial tasks 52 or complex tasks requiring manipulation (Lewis, Slabosz, Robbins, Barker, & Owen, 2005) . 53
Maintenance of WM is also impaired in PD (Fallon, Mattiesing, Muhammed, Manohar, & 54 Husain, 2017), though a meta-analysis of 56 WM span studies suggested that verbal 55 maintenance was reduced to a lesser extent than verbal manipulation, and that spatial WM 56 was impaired the most ( shown benefits in specific subgroups such as patients with low baseline WM (Warden, 62 Hwang, Marshall, Fenesy, & Poston, 2016) or in patients with onset of motor symptoms on 63 their left-side (Hanna-Pladdy, Pahwa, & Lyons, 2015). Importantly, many of these studies 64 may have been underpowered, with small sample sizes (n=7-28) exacerbated by between-65 subjects designs, which may contribute to the conflicting results. 66 Dopamine can also impair WM, perhaps due to an overdosing of intact areas of the 67 brain (Cools & D'Esposito, 2011) . This is more often seen in healthy participants than 68 patients (Bloemendaal et al., 2014 ; Fallon, van der Schaaf, Ter Huurne, & Cools, 2016), 69 although benefits of dopamine are also seen (Fallon et al., 2016; Naef et al., 2017) as are no-70 effects (Linssen, Vuurman, Sambeth, & Riedel, 2012); this may reflect different optimal 71 levels of dopamine for different functions within WM such as maintenance and manipulation. 72
Interestingly, in one of these studies testing WM following administration of methylphenidate 73 (a dopamine and noradrenaline reuptake inhibitor), both beneficial and deleterious effects 74 were demonstrated in the same group of participants (Fallon et al., 2016) ; methylphenidate 75 improved distractor resistance on a spatial WM task, but impaired flexible updating of 76 information held in WM. This suggests that the 'overdose' effects reported in some studies 77 may not be seen when using broad measures of WM but require specific measurement of the 78 different underlying processes. 79
We hypothesised that PD would impair maintenance and manipulation of WM, and 80 that dopaminergic medication would remediate the deficits in PD patients while 'overdosing' 81 and impairing WM in healthy older adults. We used a simple WM measure, the digit span 82 (Wechsler, 2008) , which is commonly given in neuropsychological assessments. We used 83 three variations of the digit span (forwards, backwards, sequence recall) with different 84 contributions of maintenance and manipulation processes. This was given to a large sample 85 of PD patients ON and OFF their normal dopaminergic medication and healthy age-matched 86 controls (HC), and a separate group of healthy older adults after administration of placebo or 87 levodopa. 88
METHODS 89
Ethical approval 90 Data are presented from several different studies running under different ethical 91 approvals. Experiment 1 studies were approved by Frenchay and Southwest Central Bristol 92 NHS RECs. Experiment 2 was approved by University of Bristol Faculty REC. All 93 procedures were carried out in accordance with the relevant guidelines and regulations. All 94 participants gave written informed consent, in accordance with the Declaration of Helsinki.
Participants

96
Experiment 1 97
Demographic details for all groups are presented in Table 1 . 98
To generate a good sample size, we applied a robust, consistent protocol for testing 99 digit span across several different studies. In total, we collected data from 68 PD patients and 100 83 HC who all performed the digit span (as well as other cognitive tasks dependent on study). 101
Patients with a diagnosis of idiopathic PD were recruited from neurology and movement 102 disorder clinics at Southmead and Frenchay Hospitals in Bristol, UK. All were taking 103 levodopa and/or dopamine receptor agonists, were not taking irreversible mono-amine 104 oxidase inhibitors or acetylcholinesterase inhibitors, and did not have deep-brain stimulators 105 implanted. They had no serious neurological disorders other than PD and had normal or 106 corrected vision and hearing. 107 HC were recruited from our healthy volunteer database. They were 55 years or older, 114 had no neurological disorders, were not taking dopaminergic medications, and had normal or 115 corrected to normal vision and hearing. 116
Experiment 2 117
We recruited 35 healthy older (65+ years) adults from volunteer databases and Join 118
Dementia Research databases. The same inclusion/exclusion criteria as for the HC group 119 above were used, as well as contraindications and medical exclusions pertaining to the drugs 120 administered (see Supplementary Materials 1 for full exclusion criteria). Two participants 121 withdrew before completing one session, and three withdrew before completing both the drug 122 and placebo session, leaving data from 30 participants analysed here. 123
Procedure
124
In the digit span, the experimenter reads aloud a list of digits at a rate of 1 per second 125 and the participant must repeat the list back. All digits must be in the correct order for the list 126 to be marked correct. The lists start at a length of 2 digits, and two lists of each length are 127 read out. The list lengths increase by 1 digit until the participant gets both lists of the same 128 length correct. 129
There are three components of the digit span: in the forwards span, the list must be 130 recalled in the same order as said by the experimenter; in the backwards span, participants 131 must repeat it in the reverse order to presentation order; in the sequence span, participants 132 must recall the list in ascending numerical order. Forwards and sequence components present 133 two lists of each length from 2-9 digits. The backwards component presents four lists of 2 134 digits length, then two lists from lengths of 3-8 digits. There are 16 lists in total for each 135 component.
Experiment 1 137
PD patients completed the three components (forwards, backwards, sequence) of the 138 digit span once ON and once OFF medication (medication order randomised and 139 counterbalanced), while HC completed it once. When coming OFF medication, PD patients 140 were withdrawn from standard release dopaminergic medication for a minimum of 16 hours 141 and from long-lasting dopaminergic medications for a minimum of 24 hours. 142
Experiment 2 143
This was a within-subjects double-blinded, placebo-controlled study. The participants 144 completed both the drug and placebo conditions, in a randomised, counterbalanced order. 145
Healthy older adults received 10mg/ml domperidone or a placebo, followed by 146 187.5mg co-beneldopa (150mg levodopa, 37.5mg benserazide) or a second placebo. Neither 147 participant nor experimenter knew on which visit the participant received the drug or placebo. 148
Their heart rate and blood pressure were monitored before and after administration. After 1.5 149 hours they completed the digit span, along with other cognitive tests. 150
Data analysis
151
We used several scoring measures for the digit span to capture different sources of 152 errors. The maximum span length correctly recalled gives a measure of the maximum 153 capacity of a participant's WM. This is calculated for each span component (forwards, 154 backwards and sequence) separately. 155
People can also make errors even before they have hit their capacity limit, which is 156 not picked up by the maximum span measure. There are several measures sensitive to the 157 number of errors in WM which reflect WM accuracy rather than capacity. The number of 158 lists recalled correctly gives a simple count of these errors but is confounded by the fact that 159 people with smaller capacities will exit the test earlier and thus not attempt as many lists as 160 someone with a larger span. Therefore, we analysed the percentage of lists recalled correctly, Table 2 ). Paired t-tests showed no significant differences between PD ON and OFF dopaminergic medication on any span (forwards: t (67) 187 = 0.944, p = .348, d = 0.102; backwards: t (67) = -.309, p = .758, d = 0.032; sequence: t (67) 188 = 0.456, p = .650, d = 0.049). 
194
PD patients made more errors (i.e. lower percentage of lists correct) than HC only for 195 the manipulation spans (see Fig 2; backwards: F (2, 216) = 9.060, p = .0002, 2 = .077; 196 sequence: F (2, 216) = 6.410, p = .0020, 2 = .056) but not for the forwards span (F (2,216) = 197 1.818, p = .1648, 2 = .017). Dopaminergic medication did not affect the percentage of lists 198 correct (forwards: t (67) = -1.236, p = .2208, d = 0.147; backwards: t (67) = 2.011, p = .0483, 199 d = 0.281; sequence: t (67) = 1.436, p = .1556, d = 0.167). 
205
As PD patients had lower maximum spans on the forwards component, but did not 206 have lower percentage of lists correct, we compared these two measures directly. We 207 converted maximum span length into a percentage to be on the same scale as the percentage 208 of lists correct and ran a mixed ANOVA (within-subject factor: measure type, between-209 subject factor: group (PD or HC)). The forwards component had a significant measure*group 210 interaction (F (1, 217) = 6.511, p = .011, 2 = .029) that passed the Bonferroni-corrected 211 threshold (α = .01667), while backwards (F (1, 217) = 4.641, p = .032, 2 = .021) and 212 sequence (F (1, 217) = 4.984, p = .027, 2 = .022) did not. This suggests that PD affects the 213 maximum span length and percentage of lists correct differently for the forwards component, 214 but not the backwards or sequence components. 215 
223
Looking at the healthy older adults given levodopa and placebo, levodopa did not 224 affect maximum span digit span component (forwards: t (29) = 0.516, p = .610, d = 0.070; 225 backwards: t (29) = 0.311, p = .758, d = .051; sequence: t (29) = -.0124, p = .920, d = 0.028) 226 (see Fig 1 and Table 2 ). 227
However, levodopa did decrease the percentage of lists correctly recalled for the 228 sequence component (t (29) = -2.919, p = .007, d = 0.689), though not for the forwards (t (29) 229 = -0.453, p = .654, d = 0.072) or backwards (t (29) = -0.452, p = .654, d = 0.085) components 230 (see Fig 2) . No effects of weight-adjusted levodopa dose were seen (see Supplementary  231 Materials 2). 232
Only two participants from Experiment 2 had their error responses recorded, so the 233 percentage of digits correct were not analysed for Experiment 2. 234
DISCUSSION 235
PD patients had lower maximum spans for each component of the digit span, as well 236 as lower percentage of lists recalled correctly for backwards and sequence spans. 237 Dopaminergic medication did not improve performance on any component or measure in PD 238 patients. In healthy older adults, levodopa did not affect maximum span, but did decrease the 239 percentage of lists correctly recalled for the sequence span. 240 PD patients were only impaired on the maintenance component (forwards digit span) 241 when measuring the maximum span length recalled, not the percentage of lists correct. 242
However, for the manipulation components (backwards and sequence spans) PD impaired the 243 maximum capacity and percentage of lists correct similarly. This distinction suggests that the 244 two measures are tapping into distinct processes during WM -the capacity and the accuracy. 245
It also suggests that PD impairs the capacity for maintenance and manipulation processes, but 246 only reduces accuracy of manipulation processes. This aligns with previous literature which 247 has suggested that while PD does lead to more decay of precision of items held in memory 248 (Fallon et al., 2017; Zokaei et al., 2015) , there are greater deficits when manipulation is 249 required (Lewis et al., 2005) and that this is due to increased number of errors (Fallon et al., 250 2017) . measure. This suggests that the lack of effect is not simply due to smaller differences between 258 the groups but may reflect different processes underlying the data. 259
The general deficit in WM capacity could reflect a reduction in the number of items 260 that can be maintained in WM having a knock-on effect onto the manipulation components in 261 the backwards and sequence spans. If PD reduces the number of items a person can hold in 262 their memory, then this would also reduce the maximum spans possible in the backwards and 263 sequence components. This is unlikely to be the sole driver of this deficit however, as 264 backwards and sequence components had lower mean maximum spans than the forwards 265 component, meaning they were not hitting the ceiling imposed by the maintenance capacity 266
and that there is an extra source of error in these manipulation spans. 267
If PD harms WM but dopaminergic medication does not improve it, then a non-268 dopaminergic pathology is suspected. PD patients have alterations to many neuromodulatory 269 systems including noradrenaline, acetylcholine and serotonin (Jellinger, 1991; Scatton, 270 Javoy-Agid, Rouquier, Dubois, & Agid, 1983), which may underlie the deficit. Alternatively, 271 it could be a dopaminergic pathology, but simply one that is too severe to be repaired by 272 dopamine replacement therapy, although this seems unlikely given that motor symptoms, 273 usually seen before cognitive changes, are still helped by dopaminergic medication, as 274 evident in the reduced UPDRS scores in PD patients when ON medication. 275
More interesting is the apparent sparing of maintenance accuracy from the WM 276 deficit caused by PD. This could suggest that the underlying processes accounting for errors 277 on the spans is different when manipulation of the items is required, as PD seems to reduce 278 the maximum number of items that can be maintained in WM, without increasing errors 279 made. To explain this, we invoke the multicompartment model of WM (Baddeley, 2003) , 280 which posits a phonological loop for storage of items, and a central executive that mediates 281 manipulation of items stored. We propose that PD impairs the capacity of the phonological 282 loop, without increasing errors in storage under this limit, and also impairs the central 283 executive's ability to interact with items stored. 284
The pattern of results from Experiment 2 suggest that levodopa does not affect the 285 maximum capacity of any of the span types but may reduce the percentage of lists recalled 286 correctly only for the sequence span. This induced deficit supports the dopamine overdose 287 hypothesis which posits that dopaminergic drugs will overdose intact functioning in the brain, 288 leading to impairments (Cools & D'Esposito, 2011) . That manipulation accuracy was reduced 289 by levodopa corroborates reports that methylphenidate impairs the flexible updating of WM 290 information (Fallon et al., 2016) , which would be needed in the sequence span. However, this 291 effect should be interpreted with caution. Unlike the pattern of effects seen in PD patients, 292 this one is isolated. There were no impairments on the other manipulation component (the 293 backwards span); indeed, the percentage of lists correct for backwards span was not even 294 close to significantly different. Therefore, while it may be that levodopa does impair 295 manipulation accuracy of WM items, it is also possible that this is simply an artefact or false 296 positive. 297
There are several drawbacks in using the digit span that should be considered. As only 298 two lists of each length are presented, it provides a very noisy measure of performance. 299
Adapted versions presented via computer are available which use give repeated presentations 300 of list lengths, and do not quit when they fail to recall the lists but instead decrease the length 301 and then increase it back up if they recall that one correctly (Woods et al., 2011) . This step-302 up/step-down procedure is more sensitive to people's maximum capacities. Computerised 303 assessment would also rule out any variability induced by slightly different speaking speeds, 304 accents, volume, and diction, from different experimenters, which may have affected 305 performance. Other computerised tasks are available which provide analogue error measures 306 on WM, which have shown far greater sensitivity than the digit span (Zokaei et al., 2015) . 307
Work with these tasks has suggested that WM capacity may not be determined by the number 308 of discrete 'slots' for information but rather by the allocation of a shared capacity resource 309 (Bays, Catalao, & Husain, 2009; Schneegans & Bays, 2016) . Future work with these more 310 sensitive tasks will be able to separate out the specific WM processes impaired by PD and 311 affected by dopamine. 312
In summary, PD impaired maximum capacity of maintenance spans, and the capacity 313 and accuracy of manipulation spans. Despite this, PD patients show no benefit of 314 dopaminergic medication on maintenance or manipulation of WM, suggesting a non-315 dopaminergic deficiency. Levodopa also did not affect WM capacity in healthy older adults, 316 but may have decreased accuracy on manipulation span, although this effect should be 317 viewed with caution. 318
